Tuesday 28 August 2018

Clear brine fluids market to grow at a CAGR of 11.9% from 2014 to 2020: Grand View Research, Inc.

North America clear brine fluids market value by product, 2012 - 2020 (Kilo Tons)

In 2013, the global clear brine fluids market was worth USD 926.7 million. As of May 2013, the count for global rig was noted to be around 3,400. This increase in drilling activities has driven the demand for global rig count which has also contributed to fuel the growth of clear brine fluids market across the globe.
Move towards the growth of alternative energy resources such as CBM, tight gas, and shale gas mainly in China and the U.S. is anticipated to drive the growth of the global market. The Golden Triangle denotes oil & gas reserves of deep water wrapping offshore Brazil, offshore West Africa and the U.S. Gulf of Mexico (USGOM). Moreover, increased investment for deep water investigation mainly in the region is also projected to increase the demand for global clear brine fluids market. Egypt, Gulf of Mexico, the U.S., China, and Russia experienced increased drilling activities on account of rising demand for energy which is likely to drive the market.
Potassium chloride consumption accounted for over 20% of the global market in 2013. This was the largest product segment in the same year and is also anticipated to have the highest growth rate of over 10% from 2014 to 2020. Potassium chloride is most widely used for servicing wells in oil & gas industry. Wide applications range of all the bromides and chloride are expected to drive the global market. These are favored above conventional drilling muds on account of their effectiveness and cost efficiency. Primary applications of potassium chloride and bromide fluids take account of deep water wells, high & deep pressure oil sands and oil wells where general drilling muds are susceptible to block the foundations.
North America accounted for over 60% of the global clear brine fluids market in 2013. Shale gas flourishing in the U.S. is projected to provide the region with an upper hand over the forecast period. Asia Pacific market is anticipated to experience highest growth rate in production capabilities of over 10% from 2014 to 2020. Growing exploration activities in India along with the thriving oil & gas segment is projected to further boost the growth of clear brine fluids market in the region.
The global clear brine fluids market is amalgamated with four companies leading the market with over 50% market share and is characterized by a high threat of new entrants. Major industry participants include TETRA Technologies, M-I SWACO, Israel Chemicals Ltd., Halliburton, Albemarle Corporation and Great Lake Solutions. These companies are taking steps to gain a competitive advantage and to increase their product line.
Full Research Report On clear brine fluids market Analysis:
http://www.grandviewresearch.com/industry-analysis/clear-brine-fluids-market

Further key findings from the study suggest:
·         Global clear brine fluids market demand was 1,010.2 kilo tons in 2013 and is expected to reach 1,977.5 kilo tons by 2020, growing at a CAGR of 10.1% from 2014 to 2020.
·         North America emerged as the leading regional market for clear brine fluids and accounted for 64.9% of total market volume in 2013. Increasing drilling activities in the U.S. on account of shale gas boom and in Gulf of Mexico remained a key driving factor for the regional market.
·         Asia Pacific is expected to witness the highest growth at 11% over the next six years.  Increasing drilling activities in China on account of presence of large amount of untapped shale gas in place is expected to remain a key driving factor for the regional market. European clear brine fluids market is expected to reach USD 162.3 million by 2020, growing at a CAGR of 12% from 2014 to 2020.
·         Global clear brine fluids market is moderately concentrated with top four companies including M-I SWACO, Halliburton, Israel Chemicals Ltd., TETRA Technologies accounted for over 50% of the total market. Other market participants include Albemarle Corporation, Baker Hughes Inc., Zirax Ltd., The Egyptian Mud Engineering & Chemicals Co., GEO Drilling Fluids Inc., Newpark Resources Inc. and Chemtura Corporation. Clear brine fluids market recently, witnessed number of mergers and acquisitions leading to significant opportunities for market participants.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the clear brine fluids market on the basis of product and region:
Global Clear Brine Fluids Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2020)
·         Potassium Chloride
·         Calcium Chloride
·         Sodium Chloride
·         Potassium Bromide
·         Calcium Bromide
·         Sodium Bromide
·         Others
Global Clear Brine Fluids Regional Outlook (Volume Kilo Tons; Revenue, USD Million, 2012 - 2020)
·         North America
·         Europe
·         Asia Pacific
·         RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/


prostate Cancer Therapeutics Analysis Market Is Projected to Reach a Valuation of USD 12.0 Billion by 2025 : Grand view Research, Inc.

U.S. prostate cancer therapeutics market, by drug class, 2014 - 2025 (USD Billion)

The global prostate CancerTherapeutics market is expected to reach USD 12.0 billion by 2025, according to a new report by Grand View Research, Inc. According to the American Cancer Society, approximately 1 in 7 men will be diagnosed with prostate cancer in their lifetime. As per Cancer Research, a government institute, in the UK, 46,690 new cases of prostate cancer were diagnosed out of which 11,287 patients died in 2014.
Supportive initiatives undertaken by key players in collaboration with various governments to create more awareness of clinical symptoms about prostate cancer and availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection. Early detection helps in quick and on time treatment and assists in deciding treatment regimens. In addition, major players including Astella, Inc., Sanofi, Dendreon Corporation, AstraZeneca, and Johnson & Johnson are focusing on development of effective and safe therapeutic products to treat tumor. Moreover, these players have various established brands such as Zytiga, Xtandi, Eligard, Taxotere, Provenge, and Xofigo, which hold a strong position in the market. In addition, there are many drugs in pipeline such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), and ODM-201 (Orion and Bayer), which are in their phase 3 studies and are expected to enter the market during the forecast period. In addition, patents of many existing products are expiring during the forecast period. As a result, generic products are anticipated to penetrate the market. All these factors together are expected to propel growth.
In Canada, Prostate Cancer Foundation of Canada supports research, cure, and prevention of prostate cancer through an online portal. This portal provides detailed information regarding symptoms, diagnosis, and commercially available treatment options. Such portals offer free access to people all around the world, which is resulting in growth.
Full Research Report On Prostate Cancer Therapeutics Market Analysis:
https://www.grandviewresearch.com/industry-analysis/prostate-cancer-therapeutics-market

Further key findings from the study suggest:
·         The growing incidence of prostate cancer across the globe is expected to drive growth
·         The market is segmented into hormonal therapy including Luteinizing Hormone Releasing Hormone (LHRH) agonist, LHRH antagonist & antiandrogen; chemotherapy; immunotherapy, and targeted therapy
·         Zytiga (Johnson & Johnson) is considered as a gold standard product for the treatment of prostate cancer and holds a strong position. However, Xtandi (Astella, Inc.) and Zytiga are competing with each other. The degree of competition is projected to elevate during the forecast period. Thus, hormonal therapy holds the largest share.
·         Provenge (Dendreon Corporation) is the only immunotherapy drug mainly used in the treatment of advanced or metastasis of such cancerous cells
·         In addition, there are many promising immunotherapy drugs in the pipeline such as INO-5150 SynCon and PROSTVAC (Bavarian Nordic), which are expected to enter the market in the near future. Thus, this drug class is projected to be the fastest growing segment.
·         North America dominated the global market. Rising prevalence and mortality rate associated with such tumors in the U.S. is the primary reason for the dominance of the region.
·         Asia Pacific is anticipated to be the fastest growing region over the forecast period. Rising awareness regarding prostate cancer in Asian countries including China, Japan, & India, would be the major factor driving the growth.
·         Some of the major players include, but are not limited to, Johnson & Johnson; Astella, Inc.; Sanofi; Ipsen; Bayer AG; AstraZeneca; Valeant Pharmaceuticals North America LLC (Dendreon Corporation). These major players dominate the market owing to their strong brand identity and extensive geographic reach.
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the prostate cancer therapeutics market by drug and region:
Drugs Outlook (Revenue, USD billion; 2014 - 2025)
·         Hormonal Therapy
o    Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
o  Zytiga
o  Gonax
o    Luteinizing Hormone-Releasing Hormone (LHRH) Agonists
o  Lupron
o  Zoladex
o  Eligard
o  Decapeptyl
o  Vantas
o  Others
o    Anti-Androgen
o  Xtandi
o  Casodex
o    Chemotherapy
o  Taxotere
o  Jevtana
o    Immunotherapy
o  Provenge
o    Targeted Therapy
o  Xofigo
Regional Outlook (Revenue, USD billion; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Mexico
o    Brazil
·         MEA
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/


Agar Agar Gum Analysis Market Expected to Trigger a Revenue Increase to USD 345.3 Million by 2025: Grand view Research, Inc.

 U.S. agar-agar gum market by product, 2014 - 2025 (USD Million)   

The global agar-agar gum market is anticipated to reach USD 345.3 million by 2025, according to a new report by Grand View Research, Inc. Shifting consumer preference towards animal-free products and popularity of dairy-based products to maintain healthy diets has resulted in significant market growth.
The industry is also responsible for employment generation especially for people dwelling in coastal villages where seaweed collection forms an important component of their income. The activity is crucial for rural women who do not actively participate in mainstream fishing.
Technological advancements have supported the industry as well, with the introduction of metal scrapers that may be utilized to harvest larger quantities of seaweed with less effort. Additionally, new methods & processes have been introduced to extract agar from seaweed along with other techniques for cleaning, pre-treatment, filtration & gelation, and dewatering.
Agar powders occupied over 90% of the volume share in 2015. Creative cooking methods have also paved new growth avenues for molecular gastronomy applications, with powdered gum being dissolved in boiling aqueous liquids to create unique dishes. Textured foods such as pearls and spaghetti gels, along with foamed products are important drivers for this segment.
Full Research Report On Agar-Agar Gum Market Analysis:


Further key findings from the report suggest:
·         Global agar-agar gum market was estimated at 11,236.6 tons in 2015 and is anticipated to grow at an estimated CAGR of 3.6% from 2016 to 2025.
·         Squares are widely used to make confectionaries, bakery products, desserts and other food products in the form of cubes, since the product has the ideal firmness to hold perfect molds
·         Strips or bars have also been a great alternative for gelatin derived dairy-based products and are used by industrial manufacturers that are engaged in producing kosher, halal, vegan and vegetarian foodstuffs
·         Meat is expected to increase at about 4.1% CAGR in terms of volume. Agar fosters longer shelf life to frozen & processed meat products, while also improving stability while treating these products, which has led to segment growth.
·         Microbiological & molecular applications are expected to remain an important segment, since the product is widely used to stimulate bacterial development in Petro-dishes for laboratory experiments
·         Asia Pacific is presumed expand at the highest CAGR of 5.4% in terms of revenue. The product was originally claimed to be discovered in Tarazaemon Minoya, Japan and has become an important ingredient in the regional food industry in recent years.
·         Key industry participants consist of Myeong Shin Agar, Meron Group, Marine Science Co. Ltd., Indoalgas, Able Sales Company, Orient Resources Company and Central Drug House(P) Ltd.
Grand View Research has segmented the agar-agar gum market on the basis of product, application and region:
Agar-agar Gum Product Outlook (Volume, Tons, Revenue, USD Million, 2014 - 2025)
·         Powder
·         Strip
·         Square
Agar-agar Gum Application Outlook (Volume, Tons, Revenue, USD Million, 2014 - 2025)
·         Confectioneries
·         Bakery & Pastry
·         Retail
·         Meat
·         Microbiological & Molecular
·         Others
Agar-agar Gum Regional Outlook (Volume, Tons, Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S
·         Europe
o    Norway
o    France
o    Spain
·         Asia Pacific
o    China
o    Japan
o    South Korea
·         Middle East and Africa
·         Central & South America

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/

Incontinence And Ostomy Care Products Analysis Market Is Projected to Reach a Valuation of USD 42.99 Billion by 2025 : Grand view Research, Inc.


In 2012, the global incontinence andostomy care products market was worth USD 11.50 billion. Rising aging population, increasing incidences of obesity and mounting cases of unmet medical conditions of patients are few of the factors driving the market demand. 
Prevalent cases of incontinence, ulcerative colitis, inflammatory bowel diseases, Chrohn’s disease, rising health concerns and increasing patient awareness are some other factors leading to an increase in the demand for incontinence and ostomy care products. 
Increasing geriatric population is anticipated to drive the overall growth of the incontinence and ostomy care products market. As per the estimates of the World Health Organisation (WHO), global population aged over 65 years is expected to rise from 780 million in 2010 to 975 million in 2017. Thus, growth in geriatric population is expiated to result in rise in target population. According to another report from WHO, women are found more susceptible to incontinence compared to men. Therefore, women are expected to dominate the customer base of the overall market. 
Full Research Report On incontinence and ostomy care products market Analysis:
http://www.grandviewresearch.com/industry-analysis/incontinence-and-ostomy-care-products-industry

On the other hand, rising incidents of obesity, high acceptance & awareness among men population is expected to propel the growth of incontinence and ostomy care products market. As a result, the global market is expected to be valued at USD 17.2 billion by 2020.
Presently cleaners, absorbents, deodorizers, incontinence bags, clamps and urinals are widely used as incontinence care products. Absorbents segment dominated the global market with market share of more than 90 % in 2012 since, it is the most popular and commonly used product. Introduction of user friendly, personalized and innovative absorbents coupled with social acceptance of these products will drive the market growth significantly. Therefore, absorbents segment is anticipated grow at the fastest CAGR of 6 % during the period 2013-2020. 
Ostomy care products mainly include skin barriers, deodorants, ostomy bags, ilestomy and irrigation products and urostomy bags. In 2012, ostomy bags held the majority of the overall ostomy care products market with a share of over 70%. Rising prevalence of diseases such as Chrohn’s disease, inflammatory bowel disease, coupled with rising elderly population some of the primary factors boosting the growth of the market. In addition, availability of improved products such as user friendly and skin friendly bags are expected to fuel the demand for ostomy bags. Colostomy bags was the leading segment with market share of around 37% with market revenue valued worth USD 1.04 billion in 2012. 
Based on the region, the global incontinence and ostomy care market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America captured approximately 37% of the global market share in 2012. Higher disposable incomes, increased awareness regarding side effects of obesity, higher geriatric population in North America are the major factors resulting in dominance of the region in the global incontinence and ostomy care products market. 
However, Asia Pacific is anticipated to show fastest growth with CAGR of 7.6 % during 2013-2020. Large geriatric population base in Japan and China, increasing social acceptance and rising popularity of incontinence and ostomy care products in emerging economies including India and China are amongst few factors driving the market growth in Asia Pacific. Key competitors in the market are Unicharm Corporation, Kimberly-Clark Corporation, Hollister Inc., Coloplast Corporation and SCA(Svenska CellulosaAktiebolaget).
View More Reports Of This Category By Grand View Research At: https://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global incontinence and ostomy care products market on the basis of product and region:
Incontinence and Ostomy Care Product Outlook
·         Incontinence care
·         Absorbents
·         Incontinence bags
·         Others (clamps, cleaners, deodorizers, urinals)
·         Ostomy care
·         Ostomy bags
·         Colostomy Bags
·         Ileostomy Bags
·         Urostomy Bags
·         Continent ileostomy Bags
·         Continent Urostomy Bags
·         Deodorants
·         Skin barriers
·         Irrigation products
Incontinence and Ostomy Care Regional Outlook
·         North America 
·         Europe 
·         Asia-Pacific
·         RoW

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: https://www.grandviewresearch.com/